Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations : Neurovascular mechanism as a putative confounding factor

Chatelin S., Humbert-Claude M., Garteiser P., Ricobaraza A., Vilgrain V., Van
Beers B.E., Sinkus R., *Lenkei Z.*

Journal of Cerebral Blood Flow & Metabolism (2016) 36(5):954-64.

Abstract

We have recently reported cannabinoid-induced rapid changes in the structure of individual neurons. In order to investigate the presence of similar effects at the regional level, measures of brain tissue biomechanics are required. However, cannabinoids are known to alter cerebral blood flow (CBF), putatively resulting in presently unexplored changes in cerebral tissue biomechanics. Here we used magnetic resonance elastography (MRE) and flow-sensitive alternating inversion recovery (FAIR) imaging to measure in vivo alterations of mechanical properties and CBF, respectively, in the rat hippocampus, a brain region with a high density of type-1 cannabinoid receptors (CB1R). Systemic injection of the cannabinoid agonist CP55,940 (0.7 mg/kg) induced a significant stiffness decrease of 10.5 ± 1.2% at 15 minutes. FAIR imaging indicated a comparable decrease (11.3 ± 1.9%) in CBF. Both effects were specific to CB1R activation, as shown by pretreatment with the CB1R-specific antagonist AM251. Strikingly, similar rapid parallel changes of brain elasticity and CBF were also observed after systemic treatment with the hypotensive drug nicardipine. Our results reveal important drug-induced parallel changes in CBF and brain mechanical characteristics, and show that blood flow-dependent tissue softening has to be considered as an important putative confounding factor when cerebral viscoelastic changes are investigated.

Haut de page



À lire aussi...

Vendredi 29 Septembre 2017 - Ralf Stanewsky (Université de Münster,Allemagne)

 

> Lire la suite...

Drosophila Neprilysins Are Involved in Middle-Term and Long-Term Memory

Turrel O., Lampin-Saint-Amaux A., Preat T., Goguel V. Journal of Neuroscience (2016) 36(37):9535-46. Abstract Neprilysins are type II (...) 

> Lire la suite...

 


Informations Pratiques

Directeur d’unité
Thomas Preat
thomas.preat (arobase) espci.fr

Administratrice
Stéphanie Ledoux
stephanie.ledoux (arobase) espci.fr

Gestionnaire
Tu-Khanh Nguyen
tu-khanh.nguyen (arobase) espci.fr

Tél : +33 (0) 1 40 79 43 02

Nous contacter